chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: could not sleep on left side; COVID arm; Warm; itchy; Swollen; Red circle patch; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (Swollen) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was reported.  Concomitant products included SPIRONOLACTONE for Acne.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Red circle patch). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) (oral) ongoing since an unknown date at a dose of 10 mg once a day. At the time of the report, SLEEP DISORDER (could not sleep on left side), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE ERYTHEMA (Red circle patch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medicines include birth control pill
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Injection site bruising, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Low back pain; Injection site bruising; Pain in arm; Pain in hip; Early morning stiffness; This spontaneous case was reported by a physician and describes the occurrence of BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), ARTHRALGIA (Pain in hip) and MUSCULOSKELETAL STIFFNESS (Early morning stiffness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    No Medical History information was reported.   On 22-Jul-2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), ARTHRALGIA (Pain in hip) and MUSCULOSKELETAL STIFFNESS (Early morning stiffness). At the time of the report, BACK PAIN (Low back pain) and MUSCULOSKELETAL STIFFNESS (Early morning stiffness) had resolved and INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm) and ARTHRALGIA (Pain in hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was reported , No treatment medication was reported .   This case was linked to MOD-2021-164432 (Patient Link).   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Injection site urticaria
Clinical narrative: Hive like rash around injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE URTICARIA (Hive like rash around injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Hive like rash around injection site). At the time of the report, INJECTION SITE URTICARIA (Hive like rash around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Gait disturbance, Limb discomfort
Clinical narrative: LOW BACK PAIN; LEGS FELT VERY HEAVY; WALKING VERY SLOW; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (LOW BACK PAIN), LIMB DISCOMFORT (LEGS FELT VERY HEAVY), GAIT DISTURBANCE (WALKING VERY SLOW) and FATIGUE (Fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product OCTREOTIDE for Acromegaly.    The patient's past medical history included Hypertension since an unknown date, Acromegaly since an unknown date, Borderline diabetes since an unknown date, Hypersensitivity since an unknown date, Constipation since an unknown date and Back disorder since an unknown date. Concomitant products included CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, SIMETHICONE, PANTOPRAZOLE and DENOSUMAB (PROLIA) for an unknown indication.   On 26-Mar-2021, the patient started OCTREOTIDE (unknown route) 20 mg. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced BACK PAIN (LOW BACK PAIN), LIMB DISCOMFORT (LEGS FELT VERY HEAVY), GAIT DISTURBANCE (WALKING VERY SLOW) and FATIGUE (Fatigue). At the time of the report, BACK PAIN (LOW BACK PAIN), LIMB DISCOMFORT (LEGS FELT VERY HEAVY), GAIT DISTURBANCE (WALKING VERY SLOW) and FATIGUE (Fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomittant: unspecified high blood pressure medication, an unspecified medication for allergies, unspecified vitamins,
Sex: U
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Swollen lips; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen lips) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LIP SWELLING (Swollen lips). At the time of the report, LIP SWELLING (Swollen lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Lethargy
Clinical narrative: Lethargy; Discomfort; wrist pain; This spontaneous case was reported by a physician and describes the occurrence of LETHARGY (Lethargy), DISCOMFORT (Discomfort) and ARTHRALGIA (wrist pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    Concurrent medical conditions included Psoriatic arthritis and Psoriasis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy), DISCOMFORT (Discomfort) and ARTHRALGIA (wrist pain). At the time of the report, LETHARGY (Lethargy), DISCOMFORT (Discomfort) and ARTHRALGIA (wrist pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Itching; Rash; Redness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-May-2021 and was forwarded to Moderna on 25-May-2021.    This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRURITUS (Itching), RASH (Rash) and ERYTHEMA (Redness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma. Concurrent medical conditions included Penicillin allergy (chest rash,itching), Drug allergy (allergic to sulfa drug), Shellfish allergy (raw throat), Allergy (allergic to grass -tearing eyes, runny nose) and Drug allergy (allergic to topical steroids-raw throat). Concomitant products included ATENOLOL, ATORVASTATIN, TERAZOSIN, DUTASTERIDE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PRURITUS (Itching), RASH (Rash) and ERYTHEMA (Redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) (oral) at a dose of 50 milligram three times a day. On 19-Mar-2021, PRURITUS (Itching) and RASH (Rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-044285 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Had a bad reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Had a bad reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Had a bad reaction). At the time of the report, ADVERSE REACTION (Had a bad reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Heart rate increased
Clinical narrative: tired hot fast heart rate; tired hot fast heart rate; tired hot fast heart rate; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (tired hot fast heart rate), HEART RATE INCREASED (tired hot fast heart rate) and FATIGUE (tired hot fast heart rate) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) Unknown. On an unknown date, the patient experienced FEELING HOT (tired hot fast heart rate), HEART RATE INCREASED (tired hot fast heart rate) and FATIGUE (tired hot fast heart rate). At the time of the report, FEELING HOT (tired hot fast heart rate), HEART RATE INCREASED (tired hot fast heart rate) and FATIGUE (tired hot fast heart rate) outcome was unknown.            Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Injection site bruising, Musculoskeletal stiffness, Neck pain
Clinical narrative: Early morning stiffness; Low back pain; Injection site bruising; Pain in arm; Neck pain; Pain in hip; This spontaneous case was reported by a physician and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Early morning stiffness), BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm) and NECK PAIN (Neck pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bruising and Stiffness. Concomitant products included ADALIMUMAB (HUMIRA) from 22-Jul-2020 to 02-Mar-2021 for Ankylosing spondylitis.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Early morning stiffness), BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), NECK PAIN (Neck pain) and ARTHRALGIA (Pain in hip). At the time of the report, MUSCULOSKELETAL STIFFNESS (Early morning stiffness) and BACK PAIN (Low back pain) had resolved and INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), NECK PAIN (Neck pain) and ARTHRALGIA (Pain in hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-164188 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Early morning stiffness; Low back pain; Injection site bruising; Pain in arm; Neck pain; Pain in hip; This spontaneous case was reported by a physician and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Early morning stiffness), BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm) and NECK PAIN (Neck pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bruising and Stiffness. Concomitant products included ADALIMUMAB (HUMIRA) from 22-Jul-2020 to 02-Mar-2021 for Ankylosing spondylitis.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Early morning stiffness), BACK PAIN (Low back pain), INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), NECK PAIN (Neck pain) and ARTHRALGIA (Pain in hip). At the time of the report, MUSCULOSKELETAL STIFFNESS (Early morning stiffness) and BACK PAIN (Low back pain) had resolved and INJECTION SITE BRUISING (Injection site bruising), PAIN IN EXTREMITY (Pain in arm), NECK PAIN (Neck pain) and ARTHRALGIA (Pain in hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-164188 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Dry eye
Clinical narrative: Dry eyes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DRY EYE (Dry eyes). At the time of the report, DRY EYE (Dry eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: stomach issues; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach issues) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach issues). At the time of the report, ABDOMINAL DISCOMFORT (stomach issues) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: sporadic finger tingling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (sporadic finger tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PARAESTHESIA (sporadic finger tingling). At the time of the report, PARAESTHESIA (sporadic finger tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and no treatment medications was reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal
Clinical narrative: Felt bad; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical hstory is provided.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FEELING ABNORMAL (Felt bad) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (Felt bad) and CHILLS (Chills) had resolved.            No treatment medication were provided.   This case was linked to MOD-2021-013381 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Influenza like illness, Nasal congestion, Nasopharyngitis
Clinical narrative: little bit of congestion; common cold; low-grade fever; Sneezing; Coughing; phlegm and muscus, described post-nasal drip; sore throat; blowing runny nose; started having symptoms described as being either flu-like or like that of the common cold; The patient's left arm hurt a little bit, described as its being sore; tired and fatigued for about three days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore), SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip) and OROPHARYNGEAL PAIN (sore throat) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Arthritis, AMLODIPINE, OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days). On 21-May-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever). On an unknown date, the patient experienced NASAL CONGESTION (little bit of congestion) and NASOPHARYNGITIS (common cold). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days) had resolved and SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Productive cough, Pyrexia, Rhinorrhoea, Sneezing
Clinical narrative: little bit of congestion; common cold; low-grade fever; Sneezing; Coughing; phlegm and muscus, described post-nasal drip; sore throat; blowing runny nose; started having symptoms described as being either flu-like or like that of the common cold; The patient's left arm hurt a little bit, described as its being sore; tired and fatigued for about three days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore), SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip) and OROPHARYNGEAL PAIN (sore throat) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Arthritis, AMLODIPINE, OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days). On 21-May-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever). On an unknown date, the patient experienced NASAL CONGESTION (little bit of congestion) and NASOPHARYNGITIS (common cold). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days) had resolved and SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: little bit of congestion; common cold; low-grade fever; Sneezing; Coughing; phlegm and muscus, described post-nasal drip; sore throat; blowing runny nose; started having symptoms described as being either flu-like or like that of the common cold; The patient's left arm hurt a little bit, described as its being sore; tired and fatigued for about three days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore), SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip) and OROPHARYNGEAL PAIN (sore throat) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Arthritis, AMLODIPINE, OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days). On 21-May-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever). On an unknown date, the patient experienced NASAL CONGESTION (little bit of congestion) and NASOPHARYNGITIS (common cold). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days) had resolved and SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed appointment for second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed appointment for second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed appointment for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed appointment for second dose) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: About the reaction I'm currently feeling after the 2nd dose.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (About the reaction I'm currently feeling after the 2nd dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (About the reaction I'm currently feeling after the 2nd dose.). At the time of the report, VACCINATION COMPLICATION (About the reaction I'm currently feeling after the 2nd dose.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Pain
Clinical narrative: incorrect dose administered; pain; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 UNK. At the time of the report, INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain) outcome was unknown.            No concomitant medications were reported.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bedridden, Cough, Headache, Hypoaesthesia oral
Clinical narrative: Bed bound; Cough; Blotchy skin; numb lilps; wheeze; Shoulder pain; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps) and WHEEZING (wheeze) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002c214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (tree nuts), Pollen allergy, Allergy to animal (dogs) and Allergy to animal (cats).    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps), WHEEZING (wheeze), ARTHRALGIA (Shoulder pain), HEADACHE (Headache) and PYREXIA (Fever). On 25-May-2021, BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps), WHEEZING (wheeze), ARTHRALGIA (Shoulder pain), HEADACHE (Headache) and PYREXIA (Fever) had resolved.            This case was linked to MOD-2021-076400 (Patient Link).
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rash macular, Wheezing
Clinical narrative: Bed bound; Cough; Blotchy skin; numb lilps; wheeze; Shoulder pain; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps) and WHEEZING (wheeze) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002c214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (tree nuts), Pollen allergy, Allergy to animal (dogs) and Allergy to animal (cats).    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps), WHEEZING (wheeze), ARTHRALGIA (Shoulder pain), HEADACHE (Headache) and PYREXIA (Fever). On 25-May-2021, BEDRIDDEN (Bed bound), COUGH (Cough), RASH MACULAR (Blotchy skin), HYPOAESTHESIA ORAL (numb lilps), WHEEZING (wheeze), ARTHRALGIA (Shoulder pain), HEADACHE (Headache) and PYREXIA (Fever) had resolved.            This case was linked to MOD-2021-076400 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Sore arm for a day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore arm for a day) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Sore arm for a day). At the time of the report, INJECTION SITE PAIN (Sore arm for a day) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 vaccine) was not applicable    No treatment drugs were reported   This case was linked to MOD-2021-014582 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient miss his second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient miss his second dose) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient miss his second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient miss his second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles/Nerve pain/Lot of pain/Rash under arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles/Nerve pain/Lot of pain/Rash under arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced HERPES ZOSTER (Shingles/Nerve pain/Lot of pain/Rash under arm). The patient was treated with LYSINE at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles/Nerve pain/Lot of pain/Rash under arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided by the reporter. Treatment: Lysine, Valacyclovir. Patient stated  she received 1st dose of moderna covid-19 vaccine on 27Apr2021 on her right arm and due for her 2nd dose on 25May2021. She stated that she began with rash under her arm around 10May2021 and got lot of pain. On 20May2021 she visited dermatologist and they have told her that she had shingles and put her on medication. Nerve pain has subsided on 24May2021 and going away. She wanted to know if it would be okay to receive 2nd dose as she was on medication and whether shingles is the common side effect of vaccine. When she spoke to her HCP regarding this, they recommended to speak with moderna  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia
Clinical narrative: Weakness; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021 at 6:05 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever). On 09-May-2021, ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) had resolved.            This case was linked to MOD-2021-068372 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Decreased appetite, Sleep deficit
Clinical narrative: Sleep deprivation; Low appetite; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DEFICIT (Sleep deprivation) and DECREASED APPETITE (Low appetite) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLEEP DEFICIT (Sleep deprivation) and DECREASED APPETITE (Low appetite). At the time of the report, SLEEP DEFICIT (Sleep deprivation) and DECREASED APPETITE (Low appetite) outcome was unknown.            No concomitants were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm for the ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm for the ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm for the ache). At the time of the report, VACCINATION SITE PAIN (Arm for the ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 30.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Localised infection, Vaccination site movement impairment
Clinical narrative: Could not lift right arm and pain; A ball under arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift right arm and pain) and LOCALISED INFECTION (A ball under arm) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift right arm and pain) and LOCALISED INFECTION (A ball under arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Could not lift right arm and pain) and LOCALISED INFECTION (A ball under arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: Swelling in my arm pit; Sever pain in arm where the shot was given; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling in my arm pit) and VACCINATION SITE PAIN (Sever pain in arm where the shot was given) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced LYMPHADENOPATHY (Swelling in my arm pit) and VACCINATION SITE PAIN (Sever pain in arm where the shot was given). At the time of the report, LYMPHADENOPATHY (Swelling in my arm pit) and VACCINATION SITE PAIN (Sever pain in arm where the shot was given) outcome was unknown.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Amniocentesis, Arthralgia, Exposure during pregnancy, Fatigue, Myalgia
Clinical narrative: fatigue; Achiness; Joint pain; Exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Exposure during pregnancy), FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Alcoholic (1-2 drinks a week) on 15-Oct-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 21-Sep-2020 and the estimated date of delivery was 11-Jul-2021. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPOSURE DURING PREGNANCY (Exposure during pregnancy). On 11-Feb-2021, the patient experienced FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-Feb-2021, FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2020, Ultrasound scan: other (normal) No abnormal findings Ultrasound 2. On 21-Jan-2021, Amniocentesis: other (Low) Low level  10% of Mosaic Turner Syndrome. On 21-Jan-2021, Ultrasound scan: other (normal) No abnormal findings Ultrasound 2.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-015717.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: fatigue; Achiness; Joint pain; Exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Exposure during pregnancy), FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Alcoholic (1-2 drinks a week) on 15-Oct-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 21-Sep-2020 and the estimated date of delivery was 11-Jul-2021. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPOSURE DURING PREGNANCY (Exposure during pregnancy). On 11-Feb-2021, the patient experienced FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-Feb-2021, FATIGUE (fatigue), MYALGIA (Achiness) and ARTHRALGIA (Joint pain) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2020, Ultrasound scan: other (normal) No abnormal findings Ultrasound 2. On 21-Jan-2021, Amniocentesis: other (Low) Low level  10% of Mosaic Turner Syndrome. On 21-Jan-2021, Ultrasound scan: other (normal) No abnormal findings Ultrasound 2.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-015717.